Ashland ASH Life Sciences — Segment Expenditure Addition To Long Lived Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ashland in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: Ashland’s 10-K, filed November 20, 2025, on SEC EDGAR. View the filing →
Ask your AI about Ashland's life sciences — segment expenditure addition to long lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ashland's life sciences — segment expenditure addition to long lived assets?
- Ashland (ASH) reported life sciences — segment expenditure addition to long lived assets of $12.25M in Q3 2025.
- How has Ashland's life sciences — segment expenditure addition to long lived assets changed year-over-year?
- Ashland's life sciences — segment expenditure addition to long lived assets decreased by 19.7% year-over-year, from $15.25M to $12.25M.
- What is the long-term trend for Ashland's life sciences — segment expenditure addition to long lived assets?
- Over 3 years (2022 to 2025), Ashland's life sciences — segment expenditure addition to long lived assets has grown at a 20.5% compound annual growth rate (CAGR), from $28M to $49M.
- What does life sciences — segment expenditure addition to long lived assets mean?
- This metric measures the total capital investment made by the segment to acquire or improve long-lived assets, such as property, plant, and equipment. It serves as a key indicator of the company's commitment to expanding production capacity, upgrading technology, or maintaining operational infrastructure within the segment. High levels of expenditure suggest a focus on long-term growth and operational efficiency improvements.